Water channel targeted drugs
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
80
NCT03804476
Phase 1 Study to Assess AER-271
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 26, 2018
Completion: Aug 28, 2019
Loading map...